Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future

Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future

Non-alcoholic steatohepatitis (NASH) is characterized by steatosis, lobular inflammation, and enlargement of the diameter of hepatocytes (ballooning hepatocytes), with or without fibrosis. It affects 20% of patients with non-alcoholic fatty liver disease (NAFLD). Due to liver dysfunction and the num...

Full description

Bibliographic Details
Main Authors: João Paulo Margiotti dos Santos, Mariana Canevari de Maio, Monike Alves Lemes, Lucas Fornari Laurindo, Jesselina Francisco dos Santos Haber, Marcelo Dib Bechara, Pedro Sidnei do Prado, Eduardo Costa Rauen, Fernando Costa, Barbara Cristina de Abreu Pereira, Uri Adrian Prync Flato, Ricardo de Alvares Goulart, Eduardo Federighi Baisi Chagas, Sandra Maria Barbalho
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
non-alcoholic fatty liver disease
dyslipidemias
oxidative stress
inflammation
organokines
Online Access:https://www.mdpi.com/1422-0067/23/1/498

Internet

https://www.mdpi.com/1422-0067/23/1/498

Similar Items